People · Operator
Named in public records as an officer, director or promoter · active 2009–2021 · Pharmaceuticals, Biotechnology, Other, Retailing
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Diffusion Pharmaceuticals Inc. | — | Pharmaceuticals | Series C | $140.0M | $26.3M | 2011 |
| Exosome Diagnostics, Inc. | — | Biotechnology | Series B | $90.9M | $1.2B | 2015 |
| Arbor Assets Inc | — | Other | Series A | $5.0M | $56.1M | 2021 |
| Bekins Holding Corp. | — | Other | Seed | $3.0M | $55.3M | 2009 |
| BlueVault Group SoCal LLC | — | Retailing | Pre-Seed | $900K | $7.1M | 2015 |
William Kelly at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside William Kelly on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Isaac Blech | 1 | 14 |
| Sol Barer | 1 | 6 |
| Georg Nebgen | 1 | 5 |
| John Boyce | 1 | 4 |
| Paul Feller | 1 | 4 |
| David Okrongly | 1 | 4 |
| James McCullough | 1 | 3 |
| Rex Bright | 1 | 3 |
| Nelson Stacks | 1 | 3 |
| Sara Barrington | 1 | 3 |
| Peter Johann | 1 | 2 |
| David R. Jones | 1 | 2 |
| John L. Gainer | 1 | 2 |
| Geert-Jan Mulder | 1 | 2 |
| Robert W. Adams | 1 | 2 |
| David G. Kalergis | 1 | 2 |
| Joseph Boystak | 1 | 2 |
| Stephen Simes | 1 | 2 |
| Mark T. GIles | 1 | 2 |
| Ben L. Shealy | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.